Wegovy
Semaglutide
FDA-approved semaglutide for chronic weight management
Prescription weight-loss medication for adults with obesity or excess weight and related health conditions.
About Wegovy
Wegovy® contains semaglutide, a GLP-1 receptor agonist FDA-approved for chronic weight management in adults. Under clinician supervision, it supports appetite regulation and gradual, sustainable weight reduction as part of a comprehensive medical program.
Key benefits
- Supports appetite regulation through GLP-1 receptor activation
- Clinically studied for meaningful weight reduction over time
- Weekly dosing may fit more easily into busy routines
- Ongoing physician monitoring throughout titration
Who may qualify
- Adults with BMI ≥ 30, or BMI ≥ 27 with a weight-related condition
- Evaluation of medical history, medications, and contraindications
- Prescription provided only when clinically appropriate
How treatment works
Complete your evaluation
Share your health history through a secure intake and meet with a licensed clinician.
Receive a personalized plan
If eligible, your provider determines starting dose and titration schedule.
Begin supervised treatment
Medication is filled through a licensed pharmacy with follow-up visits for monitoring.
Good to know
- Not suitable for everyone; your clinician reviews risks and benefits individually.
- Common side effects may include nausea, especially during dose escalation.
- Requires ongoing medical follow-up and lifestyle support for best outcomes.
GLP-1 medications are available by prescription only after a licensed provider determines eligibility. This information is educational and not medical advice.
Common questions
Both contain semaglutide, but Wegovy is FDA-approved specifically for chronic weight management at different dosing protocols than Ozempic, which is approved for type 2 diabetes.
Many patients notice appetite changes within the first few weeks, while weight loss typically occurs gradually over months with consistent treatment and lifestyle support.
Zepbound
Tirzepatide
FDA-approved weight management medication containing tirzepatide for adults with obesity or related health conditions.
Ozempic
Semaglutide
GLP-1 prescription medication FDA-approved for type 2 diabetes and prescribed off-label for weight management.
Mounjaro
Tirzepatide
Prescription medication for adults with type 2 diabetes used in personalized provider-supervised care plans.